Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Gharghabi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biomed Research International|June 5, 2014
Human serum albumin conjugates of 7-ethyl-10-hydroxycamptothecin (SN38) for cancer treatmentNima Sepehri, Hasti Rouhani, Ahmad Reza Ghanbarpour, et al.
Artificial Cells, Nanomedicine, and Biotechnology|May 4, 2016
Biotin decorated PLGA nanoparticles containing SN-38 designed for cancer therapyMozhdeh Mehdizadeh, Hasti Rouhani, Nima Sepehri, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Allosteric degraders induce CRL5 <sup>ASB8</sup> mediated degradation of XPO1Casey Elizabeth Hudman-Wing, Ho Yee Joyce Fung, Tolga Cagatay, et al.
Nature Chemical Biology|November 25, 2025
SINE compounds activate exportin 1 degradation through an allosteric mechanismCasey E Wing, Ho Yee Joyce Fung, Bert Kwanten, et al.
Science Advances|September 16, 2022
Targeting OXPHOS de novo purine synthesis as the nexus of <i>FLT3</i> inhibitor-mediated synergistic antileukemic actionsPu Zhang, Lindsey T Brinton, Mehdi Gharghabi, et al.
Blood Cancer Discovery|December 27, 2023
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal HematopoiesisCaner Saygin, Pu Zhang, Jacob Stauber, et al.
The Journal of Clinical Investigation|March 20, 2025
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environmentPu Zhang, Ethan C Whipp, Sarah J Skuli, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biomed Research International|June 5, 2014
Human serum albumin conjugates of 7-ethyl-10-hydroxycamptothecin (SN38) for cancer treatmentNima Sepehri, Hasti Rouhani, Ahmad Reza Ghanbarpour, et al.
Artificial Cells, Nanomedicine, and Biotechnology|May 4, 2016
Biotin decorated PLGA nanoparticles containing SN-38 designed for cancer therapyMozhdeh Mehdizadeh, Hasti Rouhani, Nima Sepehri, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Allosteric degraders induce CRL5 <sup>ASB8</sup> mediated degradation of XPO1Casey Elizabeth Hudman-Wing, Ho Yee Joyce Fung, Tolga Cagatay, et al.
Nature Chemical Biology|November 25, 2025
SINE compounds activate exportin 1 degradation through an allosteric mechanismCasey E Wing, Ho Yee Joyce Fung, Bert Kwanten, et al.
Science Advances|September 16, 2022
Targeting OXPHOS de novo purine synthesis as the nexus of <i>FLT3</i> inhibitor-mediated synergistic antileukemic actionsPu Zhang, Lindsey T Brinton, Mehdi Gharghabi, et al.
Blood Cancer Discovery|December 27, 2023
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal HematopoiesisCaner Saygin, Pu Zhang, Jacob Stauber, et al.
The Journal of Clinical Investigation|March 20, 2025
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environmentPu Zhang, Ethan C Whipp, Sarah J Skuli, et al.
Pageof 2